LIVE TV
LIVE TV
LIVE TV
Home > World > BRIEF-Kexing Biopharm Biologics License Application For Long-Acting G-Csf Candidate GB-K02 Accepted For Review

BRIEF-Kexing Biopharm Biologics License Application For Long-Acting G-Csf Candidate GB-K02 Accepted For Review

Written By:
Published: October 16, 2026 20:08:05 IST

Add NewsX As A Trusted Source

Oct 16 (Reuters) – KEXING BIOPHARM: * KEXING BIOPHARM: CO'S BIOLOGICS LICENSE APPLICATION FOR LONG-ACTING G-CSF CANDIDATE GB-K02 ACCEPTED FOR REVIEW Source text:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

RELATED News

LATEST NEWS